Marina Bayeva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Marina Bayeva has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Hossein Ardehali
Department of Medicine and Sarver Heart Center, College of Medicine, The University of Arizona, Tucson
2 shared publications Adam De Jesus
Feinberg Cardiovascular Research Institute (FCVRI), Northwestern University, Chicago, Illinois, USA
1 shared publication- Brian N. Finck
Division of Geriatrics and Nutritional Science, Washington University School of Medicine, St. Louis, USA
1 shared publication - Hsiang-Chun Chang
Feinberg Cardiovascular and Renal Research Institute, Northwestern University School of Medicine
1 shared publication - Jason A. Wertheim
Department of Surgery, University of Arizona College of Medicine, Tucson, USA
1 shared publication - Jason Solomon Shapiro
Feinberg Cardiovascular and Renal Research Institute, Northwestern University
1 shared publication
Latest Publications
- Open Access
- 12 July 2018
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 3 (13)
Hepatic tristetraprolin promotes insulin resistance through RNA destabilization of FGF21
The role of posttranscriptional metabolic gene regulatory programs in diabetes is not well understood. Here, we show that the RNA-binding protein tristetraprolin (TTP) is reduced in the livers of diabetic mice and humans and is transcriptionally induced in response to insulin treatment in murine livers in vitro and in vivo. Liver-specific Ttp -KO (ls Ttp -KO) mice challenged with high-fat diet (HFD) have improved glucose tolerance and peripheral insulin sensitivity compared with littermate controls. Analysis of secreted hepatic factors demonstrated that fibroblast growth factor 21 ( FGF21 ) is posttranscriptionally repressed by TTP. Consistent with increased FGF21, ls Ttp -KO mice fed HFD have increased brown fat activation, peripheral tissue glucose uptake, and adiponectin production compared with littermate controls. Downregulation of hepatic Fgf21 via an adeno-associated virus–driven shRNA in mice fed HFD reverses the insulin-sensitizing effects of hepatic Ttp deletion. Thus, hepatic TTP posttranscriptionally regulates systemic insulin sensitivity in diabetes through liver-derived FGF21.
- 12 July 2018
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 3 (13)
Open AccessHepatic tristetraprolin promotes insulin resistance through RNA destabilization of FGF21
The role of posttranscriptional metabolic gene regulatory programs in diabetes is not well understood. Here, we show that the RNA-binding protein tristetraprolin (TTP) is reduced in the livers of diabetic mice and humans and is transcriptionally induced in response to insulin treatment in murine livers in vitro and in vivo. Liver-specific Ttp -KO (ls Ttp -KO) mice challenged with high-fat diet (HFD) have improved glucose tolerance and peripheral insulin sensitivity compared with littermate controls. Analysis of secreted hepatic factors demonstrated that fibroblast growth factor 21 ( FGF21 ) is posttranscriptionally repressed by TTP. Consistent with increased FGF21, ls Ttp -KO mice fed HFD have increased brown fat activation, peripheral tissue glucose uptake, and adiponectin production compared with littermate controls. Downregulation of hepatic Fgf21 via an adeno-associated virus–driven shRNA in mice fed HFD reverses the insulin-sensitizing effects of hepatic Ttp deletion. Thus, hepatic TTP posttranscriptionally regulates systemic insulin sensitivity in diabetes through liver-derived FGF21.
- 24 September 2010
- Published by Springer Nature in Current Hypertension Reports
- Vol. 12 (6) , 426-432
Mitochondrial Dysfunction and Oxidative Damage to Sarcomeric Proteins
Hypertension is an important risk factor for the development of heart failure. Increased production of reactive oxygen species (ROS) contributes to cardiac dysfunction by activating numerous pro-hypertrophic signaling cascades and damaging the mitochondria, thus setting off a vicious cycle of ROS generation. The way in which oxidative stress leads to exacerbation of systolic and diastolic dysfunction is still unclear, however. In skeletal muscle and ischemic myocardium, increased ROS production causes preferential oxidation of myofibrillar proteins and provides a mechanistic link between oxidative damage and impaired contractility through disruption of actin-myosin interactions, enzymatic functions, calcium sensitivity, and efficiency of cross-bridge cycling. In this review, we summarize recent findings in the fields of heart failure and sarcomere biology and speculate that oxidative damage to myofibrils may contribute to the development of heart failure.
- 24 September 2010
- Published by Springer Nature in Current Hypertension Reports
- Vol. 12 (6) , 426-432
Mitochondrial Dysfunction and Oxidative Damage to Sarcomeric Proteins
Hypertension is an important risk factor for the development of heart failure. Increased production of reactive oxygen species (ROS) contributes to cardiac dysfunction by activating numerous pro-hypertrophic signaling cascades and damaging the mitochondria, thus setting off a vicious cycle of ROS generation. The way in which oxidative stress leads to exacerbation of systolic and diastolic dysfunction is still unclear, however. In skeletal muscle and ischemic myocardium, increased ROS production causes preferential oxidation of myofibrillar proteins and provides a mechanistic link between oxidative damage and impaired contractility through disruption of actin-myosin interactions, enzymatic functions, calcium sensitivity, and efficiency of cross-bridge cycling. In this review, we summarize recent findings in the fields of heart failure and sarcomere biology and speculate that oxidative damage to myofibrils may contribute to the development of heart failure.